All posts by medical

New Era in Coral Biology Research: Scientists Have Cultured the First Stable Coral Cell Lines – SciTechDaily

By Okinawa Institute of Science and Technology Graduate UniversityApril 25, 2021

A colony of Acropora tenuis grown in a natural sea environment and transferred to an aquarium to induce spawning. Credit: OIST

The ability to culture coral cells could usher in a new era in coral biology research.

Researchers in Japan have established sustainable cell lines in a coral, according to a study published today (April 25, 2021) in Marine Biotechnology.

Seven out of eight cell cultures, seeded from the stony coral,Acropora tenuis, have continuously proliferated for over 10 months, the scientists reported.

Establishing stable cells lines for marine organisms, especially coral, has proven very difficult in the past, said Professor Satoh, senior author of the study and head of the Marine Genomics Unit at the Okinawa Institute of Science and Technology Graduate University (OIST). This success could prove to be a pivotal moment for gaining a deeper understanding of the biology of these vitally important animals.

Acropora tenuisbelongs to theAcroporidaefamily, the most common type of coral found within tropical and subtropical reefs. These stony corals are fast growers and therefore play a crucial role in the structural formation of coral reefs.

However,Acroporidaecorals are particularly susceptible to changes in ocean conditions, often undergoing bleaching events when temperatures soar or when oceans acidify. Establishing knowledge about the basic biology of these corals through cell lines could one day help protect them against climate change, explained Professor Satoh.

In the study, Professor Satoh worked closely with Professor Kaz Kawamura from Kochi University an expert in developing and maintaining cell cultures of marine organisms.

Since adult coral host a wide variety of microscopic marine organisms, the group chose to try creating the cell lines from coral larvae to reduce the chances of cross-contamination. Another benefit of using larval cells was that they divide more easily than adult cells, potentially making them easier to culture.

The researchers used coral specimens in the lab to isolate both eggs and sperm and fertilize the eggs. Once the coral larvae developed, they separated the larvae into individual cells and grew them in petri dishes.

The microscope image shows three of the cell lines established in the study, ranging in color and form. Credit: OIST

Initially, the culture attempts ended in failure. Small bubble bodies appeared and then occupied most of the petri dish, said Professor Kaz Kawamura. We later found that these were the fragments of dying stony coral cells.

In the second year, the group discovered that by adding a protease called plasmin to the cell culture medium, right at the beginning of the culture, they could stop the stony coral cells from dying and keep them growing.

Two to three weeks later, the larval cells developed into eight different cell types, which varied in color, form and gene activity. Seven out of the eight continued to divide indefinitely to form new coral cells.

One of the most exciting advancements of this study was that some of the cell lines were similar in form and gene activity to endodermal cells. The endoderm is the inner layer of cells formed about a day after the coral eggs are fertilized.

Importantly, it is the cells in the endoderm that incorporate the symbiotic algae, which photosynthesize and provide nutrients to sustain the coral.

Corals are the one of the simplest animals, with only two layers of cells (called germ layers) forming in early embryonic development an inner layer, the endoderm, and an outer layer, the ectoderm. Each germ cell layer ultimately develops into different types of cells, including digestive cells, muscle-like cells, nerve-like cells and stinging cells (cnidocytes) but how each cell type forms during development still requires investigation. Credit: OIST

At this point in time, the most urgent need in coral biology is to understand the interaction between the coral animal and its photosynthetic symbiont at the cellular level, and how this relationship collapses under stress, leading to coral bleaching and death, said Professor David Miller, a leading coral biologist from James Cook University, Australia, who was not involved in the study.

He continued: Subject to confirmation that these cells in culture represent coral endoderm, detailed molecular analyses of the coral/photosymbiont interaction would then be possible and from this, real advances in understanding and perhaps preventing coral bleaching could be expected to flow.

For Professor Satoh, his interest is in how the photosymbiotic algae cells, which are almost as big as the larval cells, initially enter the coral.

The algae are incorporated into the coral cells around a week after the larvae first develop, said Prof. Satoh. But no one has yet observed this endosymbiotic event on a single-cell level before.

The scientists also found that the coral cell lines were still viable after being frozen with liquid nitrogen and then thawed. This is crucial for being able to successfully supply the coral cell lines to research laboratories across the globe, said Professor Satoh.

The implications for future research using these cell lines are far-reaching, ranging from research on how single coral cells respond to pollution or higher temperatures, to studying how corals produce the calcium carbonate that builds their skeleton.

Research could also provide further insight into how corals develop, which could improve our ability to farm coral.

In future research, the team hopes to establish cells lines that are clonal, meaning every cell in the culture is genetically identical.

This will give us a much clearer idea of exactly which coral cell types we are growing, for example gut-like cells or nerve-like cells, by looking at which genes are switched on and off in the cells, said Professor Satoh.

Reference: 25 April 2021, Marine Biotechnology.DOI: 10.1007/s10126-021-10031-w

Read the original:
New Era in Coral Biology Research: Scientists Have Cultured the First Stable Coral Cell Lines - SciTechDaily

The (cell) medium is the message: A new tool for studying cell biology in a dish | Morgridge Institute for Research – Morgridge Institute for Research

When communications scholar Marshall McLuhan coined the famous phrase the medium is the message in the 1960s, he was saying that our understanding of an idea will be shaped by how we receive it whether its conveyed through a book, a lecture, a movie or a song.

Morgridge Institute for Research investigator Jason Cantor has an interesting equivalent for biology researchers: The medium used to grow cells in a lab has a similarly profound impact on the message cells receive on how to grow and respond.

This is the concept behind Cantors innovation of a new cell culture medium a biological research tool that since the 1950s has been as ubiquitous in labs as microscopes and pipettes. Notably, Cantor began his postdoctoral training with no prior experience in mammalian cell culture, having completed his PhD in a protein engineering lab where all of his culture work was done in bacterial cells.

Not long into his postdoc, Cantor posed a deceptively basic question: How closely do classic cell culture media reflect biochemical conditions in the human body? The answer: Not too well.

This question ultimately led to the development of Human Plasma-Like Medium (HPLM), a physiologic medium that more closely reflects the metabolic composition of human blood. Cantor reported the design and initial studies using HPLM in 2017 (Cell) while a postdoc in David Sabatinis laboratory at the Whitehead Institute/MIT in Cambridge. Since that initial publication, HPLM has generated a great deal of interest from biologists across the scientific community.

We created a kind of miniature media kitchen beginning in Davids lab and then continuing here at Morgridge, and we actually ended up providing batches of HPLM as a free-of-charge service to over 60 labs around the world, Cantor says. I think its also worth noting that the recipients were not just interested in areas of cancer metabolism and cancer biology. Instead, they really covered the spectrum across most areas of biological research that could involve the use of cultured mammalian cells.

Its exciting to see this go from publication a few years back to now officially bringing a product to market.

But now its being taken to the next level. Cantors laboratory no longer needs to continue its simultaneous role as kitchen thanks to a commercialization agreement with Thermo Fisher Scientific. The company announced in March 2021 the wide-scale availability of HPLM for the scientific community.

Its exciting to see this go from publication a few years back to now officially bringing a product to market, Cantor adds. And it should be pretty exciting to see what others discover with HPLM as well.

The innovation in cell culture media is a long time coming, as the formulations of these reagents havent changed much since Johns Hopkins physician Harry Eagle developed Minimal Essential Medium in 1955, opening the floodgates for scientists to culture mammalian cells in synthetic media with less complexity and variability than natural media like the biological fluids and tissue extracts from animals.

Cantor notes that the pioneering efforts of Eagle and others indeed allowed for decades of cell culture work and serve as a key milestone in biological research, ultimately leading to countless advances both in our understanding of basic cell biology and in drug discovery and development.

But ultimately, these classic media recipes poorly resemble biochemical conditions in the body, Cantor says. To begin to address this gap, Cantor systematically created what would become HPLM, a physiologic medium that contains more than 60 components at concentrations that reflect average values reported in human blood. Ultimately, by contrast to application-driven goals that had historically guided culture media design, such as supporting rapid cell growth or promoting the production of recombinant biomolecules, the goal was to develop a culture medium that could be used to more faithfully model human cell biology.

Recently, the Cantor lab leveraged HPLM to ask how medium composition may influence gene essentiality in cancer cells in other words, identifying genes that are critical to cell growth and survival. By performing CRISPR-based genetic screens of human cancer cells in either conventional media or HPLM, the Cantor lab together with colleagues at Whitehead Institute reported the profound impact of medium composition on gene essentiality in a study published online in Cell Metabolism in March 2021.

Cantor recalls being posed with a relatively loaded question from a colleague shortly after HPLM was initially reported: What are you going to do next once everyone else has access to this new physiologic medium? His response: What have thousands of labs across the world done over the past half century while mostly using the same small handful of traditional media?

The onus is always going to be on the scientist to identify the most interesting questions to ask and the most interesting problems to address, Cantor adds.

Read the rest here:
The (cell) medium is the message: A new tool for studying cell biology in a dish | Morgridge Institute for Research - Morgridge Institute for Research

Cell Biology Cloud Computing Market Size 2021 Global Industry Trends, Share, Growth Insight, Size, Competitive Analysis, Statistics, Regional Forecast…

Cell Biology Cloud Computing Market research report studies the market status, competition landscape, market size, share, growth rate, future trends, market drivers, opportunities, challenges

This report contains market size and forecasts of Cell Biology Cloud Computing in Global, including the following market information:Global Cell Biology Cloud Computing Market Revenue, 2016-2021, 2022-2027, ($ millions)Global top five companies in 2020 (%)

The global Cell Biology Cloud Computing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.Research has surveyed the Cell Biology Cloud Computing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Download PDF Sample of Cell Biology Cloud Computing Market report @ https://www.themarketinsights.com/request-sample/122729

Total Market by Segment:Global Cell Biology Cloud Computing Market, By Type, 2016-2021, 2022-2027 ($ millions)Global Cell Biology Cloud Computing Market Segment Percentages, By Type, 2020 (%)Public Cloud ComputingPrivate Cloud ComputingHybrid Cloud Computing

China Cell Biology Cloud Computing Market, By Application, 2016-2021, 2022-2027 ($ millions)China Cell Biology Cloud Computing Market Segment Percentages, By Application, 2020 (%)GenomicsDiagnosticsClinical TrialsPharma ManufacturingOthers

Global Cell Biology Cloud Computing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)Global Cell Biology Cloud Computing Market Segment Percentages, By Region and Country, 2020 (%)North AmericaUSCanadaMexicoEuropeGermanyFranceU.K.ItalyRussiaNordic CountriesBeneluxRest of EuropeAsiaChinaJapanSouth KoreaSoutheast AsiaIndiaRest of AsiaSouth AmericaBrazilArgentinaRest of South AmericaMiddle East & AfricaTurkeyIsraelSaudi ArabiaUAERest of Middle East & Africa

Report Customization available as per requirements Request Customization@ https://www.themarketinsights.com/request-customization/122729

Competitor AnalysisThe report also provides analysis of leading market participants including:Total Cell Biology Cloud Computing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)Total Cell Biology Cloud Computing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:AccentureAmazon Web ServicesBenchlingCisco SystemsDell EmcIBMDXC TechnologyOracleScaleMatrixIPERIONNovelBio

To Check Discount @ https://www.themarketinsights.com/check-discount/122729

Table of ContentChapter One: Introduction to Research & Analysis Reports

Chapter Two: Global Cell Biology Cloud Computing Overall Market Size

Chapter Three: Company Landscape

Chapter Four: Market Sights by Product

Chapter Five: Sights by Application

Chapter Six: Sights by Region

Chapter Seven: Players Profiles

Chapter Eight: Conclusion

Chapter Nine: Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

List of Table and FigureTable 1. Cell Biology Cloud Computing Market Opportunities & Trends in Global Market

Table 2. Cell Biology Cloud Computing Market Drivers in Global Market

Table 3. Cell Biology Cloud Computing Market Restraints in Global Market

Table 4. Key Players of Cell Biology Cloud Computing in Global Market

Table 5. Top Cell Biology Cloud Computing Players in Global Market, Ranking by Revenue (2019)

Table 6. Global Cell Biology Cloud Computing Revenue by Companies, (US$, Mn), 2016-2021

Table 7. Global Cell Biology Cloud Computing Revenue Share by Companies, 2016-2021

Table 8. Global Companies Cell Biology Cloud Computing Product Type

Table 9. List of Global Tier 1 Cell Biology Cloud Computing Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Cell Biology Cloud Computing Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. By Type Global Cell Biology Cloud Computing Revenue, (US$, Mn), 2021 VS 2027

Table 12. By Type Cell Biology Cloud Computing Revenue in Global (US$, Mn), 2016-2021

Table 13. By Type Cell Biology Cloud Computing Revenue in Global (US$, Mn), 2022-2027

Table 14. By Application Global Cell Biology Cloud Computing Revenue, (US$, Mn), 2021 VS 2027

Table 15. By Application Cell Biology Cloud Computing Revenue in Global (US$, Mn), 2016-2021

Table 16. By Application Cell Biology Cloud Computing Revenue in Global (US$, Mn), 2022-2027

Table 17. By Region Global Cell Biology Cloud Computing Revenue, (US$, Mn), 2021 VS 2027

Table 18. By Region Global Cell Biology Cloud Computing Revenue (US$, Mn), 2016-2021

Table 19. By Region Global Cell Biology Cloud Computing Revenue (US$, Mn), 2022-2027

Table 20. By Country North America Cell Biology Cloud Computing Revenue, (US$, Mn), 2016-2021

Table 21. By Country North America Cell Biology Cloud Computing Revenue, (US$, Mn), 2022-2027

Table 22. By Country Europe Cell Biology Cloud Computing Revenue, (US$, Mn), 2016-2021

Table 23. By Country Europe Cell Biology Cloud Computing Revenue, (US$, Mn), 2022-2027

Table 24. By Region Asia Cell Biology Cloud Computing Revenue, (US$, Mn), 2016-2021 continued

About us.The Market Insights is a sister company to SI Market research and The Market Insights is into reselling. The Market Insights is a company that is creating cutting edge, futuristic and informative reports in many different areas. Some of the most common areas where we generate reports are industry reports, country reports, company reports and everything in between. At The Market Insights, we give our clients the best reports that can be made in the market. Our reports are not only about market statistics, but they also contain a lot of information about new and niche company profiles. The companies that feature in our reports are pre-eminent. The database of the reports on market research is constantly updated by us. This database contains a broad variety of reports from the cardinal industries. Our clients have direct access online to our databases. This is done to ensure that the client is always provided with what they need. Based on these needs, we at The Market Insights also include insights from experts about the global industries, market trends as well as the products in the market. These resources that we prepare are also available on our database for our esteemed clients to use. It is our duty at The Market Insights to ensure that our clients find success in their endeavors and we do everything that we can to help make that possible.

Direct ContactJessica Joyal+91-9284395731 | +91 9175986728sales@themarketinsights.com

Original post:
Cell Biology Cloud Computing Market Size 2021 Global Industry Trends, Share, Growth Insight, Size, Competitive Analysis, Statistics, Regional Forecast...

New York axes stem cell funding in this year’s budget – BioEdge

In 2007, defying the conservatism of the Bush Administration, New York State created a fund for research on stem cells, including human embryonic stem cells. The New York State Stem Cell Science program (NYSTEM) was smaller than Californias US$3 billion program, but still substantial, at $600 million over 11 years.

However, it has been quietly dropped in the States current budget.

NYSTEM funded a lot of important work that would not have happened otherwise, says stem cell researcher Sean Morrison of the University of Texas Southwestern Medical Center, in Dallas. The termination of the program is a setback for New York state and for the field of stem cell biology as whole.

According to Science, Researchers expect the termination to be especially harmful to the study of human embryonic stem cells.

However, the program has experienced serious problems in recent years and has only distributed $400 million so far.

In 2016, its board stopped meeting and reporting expenditures on its website, and since then awards have been inexplicably delayed: Researchers who applied in 2016 say they received money only in 2018 after several meetings in the governors office. And those who applied for last years grantswhich were expected to support up to 70 projects with $50 million over 3 yearssay they never received any official response.

Perhaps the States budget is just too tight in the Covid-19 era. A government official told Science that stem cell science should advance within academic and private research communities rather than the Department of Health, which is focused on its core mission of delivering direct services and achieving positive health outcomes for all New Yorkers.

Michael Cook is editor of BioEdge

See more here:
New York axes stem cell funding in this year's budget - BioEdge

New human biology major to be offered starting fall 2021 – The Aggie

Professors Aldrin Gomes and Ken Kaplan give insight into the majors unique opportunities and subject matter

The new human biology major is currently only open by lottery to College of Biological Sciences students who entered UC Davis as freshmen and have met other requirements detailed on the majors website200 students will be admitted into the major starting fall 2021.

Professor Ken Kaplan, the vice-chair of the Department of Molecular and Cellular Biology, and Professor Aldrin Gomes co-created the major, which will be offered to students with second-year status. According to Kaplan, human biology is a topic central to biological sciences that hasnt been given a sufficient platform at UC Davis.

A lot of us in biology think all the time about human biology whether we study model organisms or not, so its central to how we think, and I think theres a recognized need to help students see that, Kaplan said. [Weve] got micro[biology] majors, neurobiology majors and cell biology majors and they all study different organisms, but this is an opportunity to really focus our teaching on human systems in a way that we havent had a chance to do.

Jasmine Taros, a second-year biological sciences major, said she had been considering other majors as she approached her third year at UC Davis and wished she could apply to a major that involved the human side of biology.

I was thinking about cell bio and I was even thinking to myself, I wish they had a human bio major, because ever since a young age, Ive always liked bio but [] always liked the chapters that have to do with the human bio rather than the plant part, Taros said.

Professor Aldrin Gomes, the vice-chair of the neurobiology, physiology and behavior (NPB) major, believes that the new major will allow students to take more diverse biology classes than other majors in the college.

We wanted something where students can actually have access to anything in other majors that they thought [was] very useful for them going forward, Gomes said. For example, in a microbiology lab, if a student was only an NPB major, [] it wouldnt give credit toward [their] major, Gomes said. Now, they can still do things like that and get credit toward the major.

One of Kaplans motivations for wanting to implement the human biology major was that it integrates a wide array of laboratory subjects, whereas labs in other College of Biological Sciences majors have a more narrow focus.

To me, one thing thats super exciting is that now, students can satisfy their laboratory requirements [] choosing from this menu of really exciting laboratory courses that span microbiology, biochemistry, physiology, Kaplan said. Theres just so many opportunities for them to pick from these laboratory choices that they may not have had access to before.

As a part of most majors within the College of Biological Sciences, students will take certain upper-division restricted electives pertaining to their major. According to Kaplan, the new majors restricted electives will incorporate both the natural science and social science concepts necessary to understand human biology.

We will have courses from anthropology introduced as one of those restrictive electives, so not only do they get courses that were used to teaching here, but theyre going to get exposed to human biology from different perspectives across the university, Kaplan said. My vision is that we continue to work on bringing in those kinds of courses from outside because human biology is more than just the molecules and the genes and the proteins and the organs, its also how it affects society, [] medicine and policy.

Gomes said that he and Kaplan plan to increase the number of students in the major after five years.

The tentative plan was for five years at a cap of 200 because we want to give a good experience to students and if problems arise, we want to be able to handle it and get a well-oiled major before we start to let everyone who wants to do it in, Gomes said.

Gomes and Kaplan plan to continue revising the major as it progresses.

It allows us now to leverage the strengths of all the departments instead of just one department to really create something that is like a live-in document which you continue to improve, and in future years, were actually thinking about specific courses to add that will add value to the major, Gomes said.Written by: Lyra Farrell features@theaggie.org

Originally posted here:
New human biology major to be offered starting fall 2021 - The Aggie

High-yield topics and the MCATwhat pre-meds should know – American Medical Association

In preparing for the Medical College Admission Test (MCAT), studying high-yield topicsthose that appear most frequently in the exams four sectionscan pay dividends.

"The mistake test-takers make is they tend to want to treat everything equally, not realizing that there is a proportions game that comes into play," said Petros Minasi, Kaplan's senior director of pre-health programs. "Pre-med students should be strategic on where they are putting their emphasis."

Still, defining which topics qualify as high-yield and how to best cover them is tricky. An expert on MCAT prep, Minasi offered his insight.

What are the high-yield topics?

Certain topics are simply more commonly tested than others. Minasi offered a listbased on Kaplans experience with the examby the types of sciences the exam covers.

These largely apply to three MCAT sections: biological and biochemical foundations of living systems; chemical and physical foundations of biological systems; and psychological, social and biological foundations of behavior. The critical analysis and reasoning skills (commonly referred to as CARS) is largely based on inference.

Biological sciences: Biochemistry of proteins, enzymes, amino acids, DNA, molecular biology, oxidative phosphorylation, and general cell biology.

Physical sciences: Thermodynamics, chemical reactions, oxidation reduction, and acids and bases.

Physics: Kinematics, forces, work, torque, waves and electrostatics.

Behavior sciences: Learning and memory, demographics, social behavior and group psychology.

Additional tidbits

Cover the basics. Some of the topics above are more advanced concepts, but to truly understand them, youll need to cover the basics.

"Some topics might not be directly tested at higher yield, but are indirectly tested. A perfect example for this is organic chemistry. While there are some questions on the MCAT that test organic chemistry directly, there are a lot of questions, particularly in biochemistry, that require a strong working knowledge of it in order to get the questions correct."

Topics alone arent enough. "Students need to build a study plan that includes all of the scientific topics, with extra emphasis on the higher yield topics, but will also want to practice the critical thinking skills that are simultaneouslytested on the MCAT," Minasi said.

Practice makes perfect. The AMA and Kaplan have collaborated on a library of MCAT stumpers that can help pre-meds prepare for the exam. TheAMA pre-med glossary guidehas the answers to frequently asked questions about medical school, the application process, the MCAT and more. Kaplan also offers free study plans for prospective test takers.

Read more:
High-yield topics and the MCATwhat pre-meds should know - American Medical Association

Update Report on Global Cell Biology Test Kits Market 2021, Analysis by Types, Application and Key Manufacturer- Thermo Fisher Scientific, Bio-Rad,…

Report Overview

This report regarding the Cell Biology Test Kits market studies the latest trends prevalent in the industry covering the overall market with an exhaustive analysis. This includes quantitative and qualitative assessment of a market with the results used to study the market growth. The market overview contained in this report gives the market definition along with the product specifications and applications. It also contains information on the manufacturing methods prevalent in the Cell Biology Test Kits industry.

The market data collected from the period 2021-2027 has been used to scrutinize the market analysis in terms of the specific market movements regarding the markets overall progression.

Request for Sample Copy of Report @ https://www.reportsandmarkets.com/sample-request/global-cell-biology-test-kits-market-research-report-2021?utm_source=clarkcountyblog&utm_medium=15

Major Players are- Thermo Fisher Scientific, Bio-Rad, PromoCell, Merck, Universal Biologicals, PerkinElmer, TaKaRa, Promega, MOLECULAR DEVICES, NanoEntek, BIOQUOCHEM, and Bio Basic

Global Cell Biology Test Kits Market Dynamics:

The report begins with a market overview and moves on to cover the growth prospects of the Cell Biology Test Kits market. A detailed segmentation analysis of the Cell Biology Test Kits market is available based on manufacturers, regions, type, and applications in the report. The analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend, and proposals.

The report focuses on the Cell Biology Test Kits in the global market, especially in North America(U.S., Canada, Rest of North America), Europe(UK, Germany, France, Italy, Spain, Rest of Europe), Asia Pacific(China, Japan, India, Southeast Asia, Rest of Asia Pacific), Latin America(Brazil, Argentina, Rest of Latin America), Middle East and Africa(GCC Countries, South Africa, Rest of the Middle East & Africa)

This report also presents product specification, manufacturing process, and product cost structure, etc. Production is separated by regions, technology, and applications. Other important aspects that have been meticulously studied in the Cell Biology Test Kits market report is Demand and supply dynamics, import and export scenario, industry processes and cost structures, and major R&D initiatives. In the end, the report includes Cell Biology Test Kits new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis.

Method of Research

The research conducted by the team working on the report has been done in a qualitative and quantitative manner to present a comprehensive study of the market and statistics. The research looks into the different aspects of the market while conducting primary and secondary research. The study also comprises of a company analysis carried out to evaluate securities, collect business information and study the companys profile, products, and services. The other research methodologies adopted also include a framework of macro-environmental factors used in the environmental scanning component of strategic management. Apart from Porters Five Forces analysis and SWOT analysis to study the competitive landscape, PEST analysis has been conducted to examine the opportunities and threats due to Political, Economic, Social, and Technological forces.

Questions are answered in Cell Biology Test Kits Market report:

All of these questions are answered using industry-leading techniques and tools as well as a vast amount of qualitative research.

Regional Analysis

The region-wise study conducted by the report looks into the key market indicators and factors affecting each regional market. The regional analysis has categorized the production, apparent consumption, export and import in the major regions covering all the key countries. In order to present the Cell Biology Test Kits market landscape coverings the consumer and commercial markets have been analyzed. The report also covers the manufacturers in these regions regarding the manufacturing sites, capacity, production, ex-factory price, revenue, and market share in the global market. The report provides a comprehensive outlook presenting the market prospects and forecast for the period 2021-2027.

Table of Contents: Cell Biology Test Kits Market

Chapter 1: Overview of Cell Biology Test Kits Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Inquiry for Buying report @ https://www.reportsandmarkets.com/sample-request/global-cell-biology-test-kits-market-research-report-2021?utm_source=clarkcountyblog&utm_medium=15

In conclusion, it is a deep research report on the global Cell Biology Test Kits industry. Here, we express our thanks for the support and assistance from Cell Biology Test Kits industry chain related technical experts and marketing engineers during Research Teams survey and interviews.

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Here is the original post:
Update Report on Global Cell Biology Test Kits Market 2021, Analysis by Types, Application and Key Manufacturer- Thermo Fisher Scientific, Bio-Rad,...

Top Key-Players To Be Restored To The First Position In The Recombinant Cell Culture Supplements Market The Courier – The Courier

The Recombinant Cell Culture Supplements Market report by Persistence Market Research is focusing on the fact that healthcare providers are into collection of socioeconomic information of the patients, so that tracking at any point of time is possible. This on-the-go monitoring is amongst the ongoing trends in the healthcare industry.

Adoption of recombinant cell culture supplements by biopharmaceutical manufacturers and research institutes has increased significantly for the development of novel drugs and treatment. Growing demand for novel vaccines to treat and prevent severe diseases, as well as increasing stem cell research activities by biopharmaceutical manufactures are likely to pace up the lucrativeness of theglobalrecombinant cell culture supplements market.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/31310

Company Profiles

Recombinant cell culture supplements are gaining higher adoption in mammalian cell production processes in different production units and research centres. Moreover, rising investments in biologics production and growing research for the introduction of innovative gene therapies are bolstering the demand for recombinant cell culture supplements.

The global recombinant cell culture supplements market was valued aroundUS$ 320 Mnin2018, and is expected to exhibit aCAGRof more than6%over the forecast period (20192029).

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/31310

Key Takeaways of Recombinant Cell Culture Supplements Market Study

Increasing requirement of recombinant cell culture supplements for mammalian cell lines and viral & protein-based vaccines production is likely to pace up market growth. Demand will continue to pick pace, with burgeoning use of supplements in cancer research, tissue regeneration, and gene therapy development,says a PMR analyst.

Product Portfolio Expansion through Acquisitions & Partnerships Key Strategy of Manufacturers

Recombinant cell culture supplement manufacturers are focusing on product portfolio expansion through partnerships and acquisition of small. In 2015, Abcam Plc signed an exclusive partnership agreement with A* STARs Institute of Molecular and Cell Biology to develop high-quality immunoassays for life science research.

Access Full Report @https://www.persistencemarketresearch.com/checkout/31310

More Valuable Insights on Recombinant Cell Culture Supplements Market

Persistence Market Research offers a unique perspective and actionable insights on recombinant cell culture supplements in its latest study, presenting historical demand assessment of20142018and projections for20192029, on the basis of product (recombinant growth factors, recombinant insulin, recombinant albumin, recombinant transferrin, recombinant trypsin, recombinant aprotinin, recombinant lysozyme, and others), application (stem cell therapy, gene therapy, bioprocess application, vaccine development, and others), source (animals, microorganisms, and humans), and end user (academic and research institutes, biopharmaceutical companies, cancer research centers, and contract research centers), across seven major regions.

Explore Extensive Coverage of Persistence Market Researchs Healthcare Industry

About us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact us:

Persistence Market ResearchAddress 305 Broadway, 7th Floor, New York City, NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales sales@persistencemarketresearch.com

Excerpt from:
Top Key-Players To Be Restored To The First Position In The Recombinant Cell Culture Supplements Market The Courier - The Courier

Tissue Repair, Mitochondrial Function and Wound Healing Explored in 2021 APS Presidents Symposium – Newswise

Rockville, Md. (April 22, 2021)Top researchers in physiology will present a three-part series exploring cellular regulation of mitochondrial function, tissue repair and wound healing. The symposia are organized by American Physiological Society (APS) President Linda Samuelson, PhD, FAPS, FAAAS, of the University of Michigan. The APS Presidents Symposium Series will be part of the APS annual meeting at Experimental Biology 2021, which will be held on a virtual platform April 2730.

Function Symposium: Regulation of Physiological Function

Tuesday, April 27, 2 p.m. Virtual Session, Room APS-1

Chair:Ole H. Petersen, CBE, FRS, Cardiff University, U.K.

Speakers:

Functions of presynaptic voltage-gated calcium channels

Annette Dolphin, PhD, FRS, FmedSci, University College London, U.K.

Crosstalk between Ca2+ and cAMP signaling in mitochondria: where, when, why

Tullio Pozzan, MD, FRS, University of Padova, Italy

New perspectives on the physiological roles of KATP channels

Colin Nichols, PhD, FRS, Washington University School of Medicine, St. Louis

The P2X7 receptor is a key modulator of mitochondrial energy metabolism

Francesco Di Virgilio, MD, University of Ferrara, Italy

Adult Cell Plasticity and Tissue Rejuvenation

Wednesday, April 28, 2 p.m. Virtual Session, Room APS-1

Chair: Linda Samuelson, PhD, FAPS, FAAAS, University of Michigan

Speakers:

Switching cell fate to regenerate liver

Stacey S. Huppert, PhD, Cincinnati Childrens Hospital

Exercise rejuvenates aging stem cells

Thomas Rando, MD, PhD, Stanford University, Stanford, California

Cellular remodeling via paligenosis

Jason C. Mills, MD, PhD, Washington University School of Medicine, St. Louis

Cellular Cross-talk to Orchestrate Tissue Repair

Thursday, April 29, 2 p.m. Virtual Session, Room APS-1

Chairs: Linda Samuelson, PhD, FAPS, FAAAS, University of Michigan; Jason C. Mills, MD, PhD, Washington University School of Medicine, St. Louis

Speakers:

Immune mediators and wound healing

Asma Nusrat, MD, University of Michigan

Mesenchymal cells promote lung regeneration

Edward E. Morrisey, PhD, Perelman School of Medicine, University of Pennsylvania

Tissue stem cells: coping with stress

Elaine Fuchs, PhD, Howard Hughes Medical Institute, The Rockefeller University, New York

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or call 301.634.7314. Find more research highlights in the APS Newsroom.

About Experimental Biology 2021

Experimental Biology is the annual meeting of five societies that explores the latest research in physiology, anatomy, biochemistry and molecular biology, investigative pathology and pharmacology. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for global exchange among scientists who represent dozens of scientific areas, from laboratory to translational to clinical research.

About the American Physiological Society

Physiology is a broad area of scientific inquiry that focuses on how molecules, cells, tissues and organs function in health and disease. The American Physiological Society connects a global, multidisciplinary community of more than 10,000 biomedical scientists and educators as part of its mission to advance scientific discovery, understand life and improve health. The Society drives collaboration and spotlights scientific discoveries through its 16 scholarly journals and programming that support researchers and educators in their work.

Go here to read the rest:
Tissue Repair, Mitochondrial Function and Wound Healing Explored in 2021 APS Presidents Symposium - Newswise

Axion BioSystems Announces Formation of Scientific Advisory Board – Business Wire

ATLANTA--(BUSINESS WIRE)--Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, announces the formation of a Scientific Advisory Board (SAB). The SAB will be chaired by Jim Ross, Ph.D., founder and Chief Technology Officer, and will work closely with Axion BioSystems management team to help identify and prioritize Axions next generation of bioelectronic products.

We are proud to have such an accomplished and diverse group of scientific experts joining our Scientific Advisory Board. The SABs expertise will be invaluable as we continue expanding our research and development activities, said Tom OBrien, CEO & President of Axion BioSystems.

The members of Axion BioSystems Scientific Advisory Board include:

Christopher Basler, Ph.D., is Professor and Director of the Center for Microbial Pathogenesis at Georgia State University. He obtained his Ph.D. from Albert Einstein College of Medicine in 1995. He became Professor of Microbiology at Icahn School of Medicine at Mount Sinai in New York City in 2013 and moved to Georgia State University in 2016. Dr Basler was elected Fellow of the American Academy of Microbiology in 2014 and was named a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis in 2016. His major research interests are understanding immune evasion and replication mechanisms of filoviruses, coronaviruses and other emerging RNA viruses.

Evangelos Kiskinis, Ph.D., is an Assistant Professor of Neurology at Northwestern University Feinberg School of Medicine, Director of the Stem Cell Core Facility, and a New York Stem Cell Foundation Robertson Investigator. He received Ph.D. from Imperial College and carried out postdoctoral training at Harvard University where he pioneered the first models of ALS using personalized stem cell-based approaches. Dr Kiskinis discoveries on excitability deficits in patient neurons using induced pluripotent stem cells (iPSCs) led to a clinical trial with a small molecule drug. His laboratory seeks to harness the power of pluripotent stem cells to understand how neuronal function is impaired in ALS/FTD patients and pediatric forms of epilepsy. He has been the recipient of prestigious fellowships from the European Molecular Biology Organization, the New York Stem Cell Foundation and the Charles A. King Trust Medical Foundation.

Alysson Muotri, Ph.D., is a Professor at the Departments of Pediatrics and Cellular & Molecular Medicine at UC San Diego. He is also the Director of the Stem Cell Program and Archealization Center at UCSD. His lab focuses on the re-creation of the human brain using stem cell technologies and brain organoids. Dr. Muotri received his Ph.D. in Genetics in 2001 from University of Sao Paulo, Brazil, and moved to the Salk Institute as Pew Latin America Fellow in 2002 for postdoctoral training in the fields of neuroscience and stem cell biology. His research focuses on brain evolution and modeling neurological diseases using human induced pluripotent stem cells and brain organoids. He has received several awards, including the prestigious NIH Directors New Innovator Award, NARSAD, Emerald Foundation Young Investigator Award, Surugadai Award, Rock Star of Innovation, NIH EUREKA Award, Telly Awards among several others.

Manu Platt, Ph.D., is a Professor at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology & Emory University. He received his Ph.D. from Georgia Tech/Emory joint program in Biomedical Engineering, and carried out postdoctoral training at MIT. Currently, his lab focuses on pediatric strokes in sickle cell disease and personalized and predictive medicine strategies for breast cancer. Dr Platts work has been successfully funded by NIH Directors New Innovator Award, International AIDS Society, Georgia Cancer Coalition, and the National Science Foundation. Dr. Platt was inducted as inducted as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) in 2019. Integrated with his research program are his mentoring goals of changing the look of the next generation of scientists and engineers to include all colors, genders, and backgrounds. Aligned with that goal, Dr. Platt co-founded Project ENGAGES (Engaging the Next Generation At Georgia Tech in Engineering and Science), with Dr. Bob Nerem in 2013.

Jiwen Zhang, Ph.D., is Vice President of Regulatory Affairs at Passage Bio, Inc. Before joining Passage Bio, she had worked at Tmunity, GE Healthcare and biopharmaceutical companies including Johnson & Johnson, Merck, Wyeth Pharmaceuticals, and Sanofi-Aventis. Dr. Zhang has extensive experience in regulatory development across multiple therapeutic areas, including anti-inflammatory, anti-viral, metabolic, hematology, bone and growth. She has also had experience in developing drug/device combination products, and medical devices used at cell therapy point of care setting. She is leading various industry initiatives through the Standards Coordinating Body, the International Standards Organization (ISO), CASSS, and Asia Pacific Economic Cooperation Regulatory Harmonization Steering Committee (APEC RHSC). Dr. Zhang obtained her Ph.D. in Neuroscience from the joint program at the Rutgers University and the University of Medicine and Dentistry of New Jersey.

For more information, please visit https://www.axionbiosystems.com/scientific-advisory-board.

About Axion BioSystems, Inc.

Axion, a life science company located in Atlanta, GA, developed the first commercial multi-well MEA system, the Maestro, an easy-to-use, non-invasive instrument that measures functional electrical signals from brain and heart cells. Axion have continued to expand on the promise of these label free, bioelectronic assays. Recently, Axion introduced the Maestro Z and ZHT systems, providing functional measures of cell growth, with specific applications in immuno-oncology and virology. Axions products are used by pharmaceutical and biotech companies, governmental agencies, and universities for disease modeling, drug safety, and drug discovery assays.

See the original post:
Axion BioSystems Announces Formation of Scientific Advisory Board - Business Wire